Clariane SE (FRA:KO2) Short Interest


FRA:KO2 Clariane SE FRA:KO2
61 GF Score
Price €4.14
GF Value €2.46
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Clariane SE Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:KO2 vs HCA, THC, DVA: Short Interest Comparison

For the Medical Care Facilities subindustry, Clariane SE's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clariane SE Short Interest vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Clariane SE's Short Interest distribution charts can be found below:

* The bar in red indicates where Clariane SE's Short Interest falls into.


FRA:KO2
61GF Score
Clariane SE FRA:KO2
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clariane SE (FRA:KO2) Overvalued in 2026?

Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued. The current stock price of €4.14 is trading 68.3% above its estimated GF Value™ of €2.46. GuruFocus considers Clariane SE to be Significantly Overvalued.

Key valuation signals for FRA:KO2:

  • Short Interest:
  • GF Value™: €2.46 vs. price of €4.14 (68.3% above fair value)
  • GF Score™: 61/100 with 9 warning signs

No single metric tells the full story. See the FRA:KO2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clariane SE Business Description

Address 21-25, Rue Balzac, Paris, FRA, 75008
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
61GF Score

Get the complete analysis for FRA:KO2

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.14
Price
€2.46
GF Value